CETUXIMAB and PYREXIA

Overview

PYREXIA is the #8 most commonly reported adverse reaction for CETUXIMAB, manufactured by ImClone LLC. There are 1,114 FDA adverse event reports linking CETUXIMAB to PYREXIA. This represents approximately 2.2% of all 51,547 adverse event reports for this drug.

Patients taking CETUXIMAB who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for CETUXIMAB, but still significant enough to appear in the safety profile.

Other Side Effects of CETUXIMAB

In addition to pyrexia, the following adverse reactions have been reported for CETUXIMAB:

• RASH — 2,235 reports
• DIARRHOEA — 1,987 reports
• OFF LABEL USE — 1,798 reports
• NAUSEA — 1,617 reports
• VOMITING — 1,372 reports
• DYSPNOEA — 1,357 reports
• NEUTROPENIA — 1,202 reports
• DEHYDRATION — 1,098 reports
• INFUSION RELATED REACTION — 1,083 reports
• MALIGNANT NEOPLASM PROGRESSION — 1,058 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does CETUXIMAB cause PYREXIA?

PYREXIA has been reported as an adverse event in 1,114 FDA reports for CETUXIMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with CETUXIMAB?

PYREXIA accounts for approximately 2.2% of all adverse event reports for CETUXIMAB, making it a notable side effect.

What should I do if I experience PYREXIA while taking CETUXIMAB?

If you experience pyrexia while taking CETUXIMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages